Pharmafile Logo
Pharmafocus logo
Advanced Search

India

Showing 15 posts of 141 posts found.

India revokes Roche’s Valcyte patent

May 19, 2010
Sales and Marketing India, Roche, patents

Indian authorities have revoked a patent granted in 2007 for Roche’s brand Valcyte, saying it had been wrongly granted.The decision was welcomed …

News

AZ signs tuberculosis drug discovery deal

May 6, 2010
Research and Development AstraZeneca, India, TB, tuberculosis

AstraZeneca and the Global Alliance for TB Drug Development are to collaborate on the discovery and development of drugs to treat tuberculosis.The two …

News
IndiaFlagWeb

Indian pharma market ‘impossible to ignore’

April 13, 2010
Sales and Marketing India, em

A new report by consultancy firm PricewaterhouseCoopers says that India will become one of the top ten sales markets by …

News
Brazil

Emerging Markets: finding your way in a Brave New World

March 1, 2010
Sales and Marketing Brazil, China, India, Russia, em, emerging markets, sales, sales force effectiveness

Ask almost any pharmaceutical marketer where the future growth lies for the industry, and the answer will be almost certainly …

Feature

Carbogen Amcis opens large-scale high-potency API plant

February 8, 2010
Manufacturing and Production Carbogen Amcis, Dishman, India

Carbogen Amcis, the Swiss subsidiary of Dishman Pharmaceuticals and Chemicals of India, has opened a new high-potency active pharmaceutical ingredient …

News
Eisai's manufacturing and research facility in South India

Eisai looks to India for API production

January 8, 2010
Manufacturing and Production, Research and Development Eisai, India

Japanese drugmaker Eisai has started operations at a manufacturing and research facility in Visakhapatnam, southern India, which will be the …

News
Chris Begley

Hospira buys Orchid generic injectables business for $400m

December 18, 2009
Manufacturing and Production Hospira, India, Orchid, injectables

Indian active pharmaceutical ingredient manufacturer Orchid Chemicals & Pharmaceuticals has signed a $400 million deal to sell the assets of …

News

Merck makes Indian bioscience acquisition

October 14, 2009
Research and Development Asia, India, Merck

 Merck KGaA has bought an Indian company specialising in research products in a deal it says will make it one …

News

GlaxoSmithKline eyes Indian deal

September 23, 2009
Sales and Marketing GSK, India

GlaxoSmithKline is said to be looking to buy an Indian firm, according to reports in one of the country's largest …

News

Expanding clinical trials in India: answering the need for training

September 8, 2009
Research and Development India, clinical trials

 India is widely seen as the most exciting country in the clinical research world. Its potential to deliver large numbers …

Feature

Indian government accepts pro-patent report

September 1, 2009
Research and Development, Sales and Marketing Asia, India, patents

The government of India has accepted the findings of a report into its patent laws, which recommends maintaining a higher …

News

Perrigo plans ‘massive transformation’ of API production

August 26, 2009
Manufacturing and Production India, Perrigo

Pharmaceutical manufacturer Perrigo has taken a majority stake in Vedants Drugs and Fine Chemicals in a move that will shift …

News

GMP violations at Indian CMO hit UK generics makers

July 8, 2009
Manufacturing and Production Asia, India

Eight manufacturers of generic medicines in the UK have been forced to withdraw batches of product from the market because …

News

Indian pharma meets Big pharma

June 17, 2009
Research and Development, Sales and Marketing India, business models, clinical trials, pharma

 

Feature

Lilly forges risk-sharing R&D alliance with India’s Zydus

April 6, 2009
Research and Development Asia, India, lilly

Eli Lilly has forged a research collaboration with India's Zydus Cadila that sees the two companies combine their efforts in …

News

Latest content

OSE Immunotherapeutics and Boehringer Ingelheim collaborate on cancer and cardio-renal-metabolic disease treatments

May 24, 2024

Nona Biosciences announced agreement with AstraZeneca for tumour targeted therapies

May 24, 2024

BioGen to acquire Human Immunology Biosciences for $1.15bn

May 23, 2024

Merck to acquire Mirus Bio for $600m

May 23, 2024

Rare disease clinical trials: the urgent need for patients to be heard

May 22, 2024